文献速递骨质疏松与代谢性骨病创伤骨科

特立帕肽改善去势大鼠种植体周围骨微结构特征

Teriparatide improves microarchitectural characteristics of peri-implant bone in orchiectomized rats.
PubMed 文献 · Osteoporos Int · 2020-05-07

该研究评估间歇性给予PTH 1-34对去势大鼠种植体周围骨修复的影响,通过micro-CT、激光共聚焦显微镜和组织学分析发现,治疗组骨质量和骨量恢复至正常水平,PTH 1-34促进明显骨形成,骨体积增加、质量改善且骨转换增高。

要点

  • 间歇性PTH 1-34使去势大鼠种植体周围BV/TV、Tb.Th和BIC显著高于ORQ组(p<0.05)。
  • TERI组上述参数与SHAM组比较无统计学差异(p>0.05)。
  • 骨转换指标MAR和NBA在TERI组最高,其次SHAM,ORQ最低(TERI vs ORQ p<0.05)。

核心结论

  • 间歇性PTH 1-34治疗去势大鼠可促进种植体周围明显骨形成,增加骨体积、改善骨质量并提高骨转换,使骨质量和骨量恢复至健康动物水平。

研究设计与样本

  • 研究将24只Wistar大鼠分为3组:健康对照(SHAM)、去势(ORQ)和去势加PTH 1-34治疗(TERI,0.5 μg/kg/day),每组在左右胫骨骨干骺端各植入一枚种植体,修复60天。

主要发现

  • TERI组BV/TV、Tb.Th和BIC参数显著高于ORQ组(p<0.05),但与SHAM组比较无统计学差异(p>0.05)。
  • 骨转换分析中MAR和NBA在TERI组最高,其次为SHAM组,ORQ组最低(TERI vs ORQ p<0.05)。

关键数值与推荐

  • TERI组给予PTH 1-34剂量为0.5 μg/kg/day,间歇给药。
  • 评估指标包括micro-CT测量的BV/TV、Tb.Th、Tb.N、Tb.Sp和BIC,激光共聚焦显微镜测量的MAR和NBA,以及Stevenel蓝和茜素红染色的组织学评估。

临床怎么用

  • 对于骨质疏松患者种植体骨整合,间歇性PTH 1-34可能促进种植体周围骨形成并改善骨质量,但需临床研究验证。

局限性

  • 研究为动物实验,样本量24只,结果外推至临床需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This study evaluated the peri-implant bone repair in orchiectomized rats receiving intermittently PTH 1-34. The treatment returned the bone quality and quantity of the animals to normal in the computerized microtomography, laser confocal microscopy, and histological analysis. The PTH 1-34 promoted marked bone formation with increased volume, improved quality, and greater bone turnover. INTRODUCTION: Osteoporosis can be a problem in implant osseointegration. So this study aimed to evaluate the quantity and quality of peri-implant bone repair in orchiectomized Wistar rats receiving intermittently administered PTH 1-34. METHODS: Animals (n = 24) were divided into 3 groups: healthy control (SHAM), orchiectomized (ORQ), and orchiectomized and treated with 0.5 μg/kg/day PTH 1-34 (TERI), and each received an implant in the right and left tibial metaphysis, which was allowed to repair for 60 days. The resultant bone formation was evaluated through computerized microtomography (micro-CT) to compare the percent bone volume (BV/TV), trabecular thickness (Tb.Th), trabecular number and separation (Tb.N, Tb.Sp), and bone implant contact (BIC) through the intersection surface (i.S) between groups. Laser confocal microscopy was used to evaluate fluorochrome areas for mineral apposition rate (MAR) and neoformed bone area (NBA). In addition, histological evaluation of calcified tissues with Stevenel blue and alizarin red staining was performed. RESULTS: Treatment with PTH 1-34 returned the bone quality and quantity of the osteoporotic animal to normal, as the TERI group presented statistically significant higher values for BV/TV, Tb.Th, and BIC parameters compared with ORQ (p < 0.05), but when compared with SHAM (p > 0.05), no statistical difference was noted. In addition, in the bone turnover analysis (MAR, NBA) for TERI, the highest results are presented, followed by SHAM, and then ORQ (TERI × ORQ: p < 0.05). CONCLUSIONS: Intermittent treatment with PTH 1-34 on orchiectomized animals promoted marked bone formation with increased volume, improved quality, and greater bone turnover in the peri-implant space, returning the bone quality and quantity to the present standard in healthy animals.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Gomes-Ferreira PHS, de Oliveira D, Frigério PB, et al. Teriparatide improves microarchitectural characteristics of peri-implant bone in orchiectomized rats. Osteoporos Int. 2020. PMID: 32383065. doi:10.1007/s00198-020-05431-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。